Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestation-Reference-Cited by-同舟云学术

Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestation

Published:2016-07-13 Issue:4 Volume:82 Page:1084-1093
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Sharma Shringi¹,Caritis Steve²,Hankins Gary³,Miodovnik Menachem⁴⁵,Hebert Mary F.⁶,Mattison Don⁷,Venkataramanan Raman¹

Affiliation:

1. Department of Pharmaceutical Sciences, School of Pharmacy; University of Pittsburgh; Pittsburgh PA USA

2. Departments of Obstetrics, Gynecology and Reproductive Sciences, Magee-Women's Hospital; University of Pittsburgh Medical Center; Pittsburgh PA USA

3. Department of Obstetrics and Gynecology; University of Texas Medical Branch; Galveston TX USA

4. Medstar Health Research Institute; Hyatsville MD USA

5. Georgetown-Howards University Center for Clinical and Translational Science; Washington DC USA

6. Department of Pharmacy and Obstetrics & Gynecology; University of Washington; Seattle WA USA

7. McLaughlin Centre for Population Health Risk Assessment; University of Ottawa, and Risk Sciences International; Ottawa ON Canada

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12990/fullpdf

Reference27 articles.

1. Epidemiology and causes of preterm birth;Goldenberg;Lancet,2008

2. Annual summary of vital statistics: 2006;Martin;Pediatrics,2008

3. Assisted reproductive technology surveillance - United States, 2006;Sunderam;MMWR Surveill Summ,2009

4. The contribution of low birth weight to infant mortality and childhood morbidity;McCormick;N Engl J Med,1985

5. For the EPICure Study Group. Neurologic and developmental disability after extremely preterm birth;Wood;N Engl J Med,2000

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaginal progesterone for the prevention of recurrent spontaneous preterm birth;American Journal of Obstetrics & Gynecology MFM;2023-10

2. What now? A critical evaluation of over 20 years of clinical and research experience with 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention;American Journal of Obstetrics & Gynecology MFM;2023-10

3. Relationship between plasma concentration of 17-hydroxyprogesterone caproate and gestational age at preterm delivery;American Journal of Obstetrics & Gynecology MFM;2023-07

4. Supporting Prospective Pregnancy Trials via Modeling and Simulation: Lessons From the Past and Recommendations for the Future;The Journal of Clinical Pharmacology;2023-06

5. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial;American Journal of Obstetrics and Gynecology;2022-05